ELTX
Elicio Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.41
−3.60%Leverage
- Debt / equity
- 1.78x
- Net debt / equity
- -1.18x
- Debt / assets
- 0.45x
- Debt / EBITDA
- -0.35x
- Net debt / EBITDA
- 0.23x
Liquidity & coverage
- Current ratio
- 2.77x
- Quick ratio
- 2.77x
- Cash ratio
- 2.55x
- Interest coverage
- -24.00x
- EBITDA / interest
- -25.64x
- Working capital
- $16.3M
Cash & dividend
- FCF / debt
- -2.67x
- Cash flow / debt
- -2.66x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026